Preferred Label : embolism and thrombosis;
MeSH definition : A collective term for pathological conditions which are caused by the formation of
a blood clot (THROMBUS) in a blood vessel, or by blocking of a blood vessel with an
EMBOLUS, undissolved materials in the blood stream.;
MeSH synonym : thrombosis and embolism;
MeSH annotation : used for searching; INDEXER: Do not use; CATALOGER: Do not use;
Origin ID : D016769;
UMLS CUI : C0085307;
Allowable qualifiers
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
HPO term
Manual BTNT mappings - CISMeF
Record concept(s)
See also (suggested by CISMeF)
Semantic type(s)
UMLS correspondences (same concept)
A collective term for pathological conditions which are caused by the formation of
a blood clot (THROMBUS) in a blood vessel, or by blocking of a blood vessel with an
EMBOLUS, undissolved materials in the blood stream.
https://www.inesss.qc.ca/covid-19/presentations-cliniques/risques-thrombotiques.html
2020
false
false
false
Canada
coronavirus infections
pneumonia, viral
embolism and thrombosis
Hypercoagulation
embolism and thrombosis
prevalence
thrombophilia
severity of illness index
prognosis
fibrinolytic agents
embolism and thrombosis
risk factors
quebec
guidelines
scientific and technical information
risk
pandemics
COVID-19
---
https://sfar.org/traitement-anticoagulant-pour-la-prevention-du-risque-thrombotique-chez-un-patient-hospitalise-avec-covid-19-et-surveillance-de-lhemostase/
2020
false
false
false
France
coronavirus infections
pneumonia, viral
embolism and thrombosis
continuity of patient care
blood coagulation tests
risk factors
heparin
guideline
inpatients
anticoagulotherapy
risk
anticoagulants
pandemics
COVID-19
---
https://ansm.sante.fr/uploads/2020/10/30/20201030-dhpc-xeljanz.pdf
2020
false
false
false
France
French
tofacitinib
guidelines for drug use
administration, oral
protein kinase inhibitors
protein kinase inhibitors
risk factors
thrombosis
embolism and thrombosis
Drug-Related side effects and adverse reactions
tofacitinib
arthritis, rheumatoid
arthritis, psoriatic
colitis, ulcerative
venous thromboembolism
tofacitinib
pyrimidines
pyrroles
piperidines
pyrimidines
pyrroles
piperidines
---
http://www.cochrane.org/fr/CD012144/medicaments-pour-la-prevention-de-caillots-apres-une-hemorragie-dans-le-cerveau
2017
false
false
false
France
United Kingdom
French
french abstract
cerebral hemorrhage
Evidence-Based medicine
antithrombotic agents
embolism and thrombosis
treatment outcome
antithrombotic agents
hemorrhage
enoxaparin
heparin
injections, subcutaneous
heparin group
stroke
randomized controlled trials as topic
fibrinolytic agents
fibrinolytic agents
---
Direct oral anticoagulants for prevention of stroke in atrial fibrillation patients
with chronic kidney disease
http://www.cochrane.org/fr/CD011373/anticoagulants-oraux-directs-versus-warfarine-pour-prevenir-les-accidents-vasculaires-cerebraux-et
2017
false
false
false
false
France
United Kingdom
French
french abstract
anticoagulants
comparative effectiveness research
administration, oral
Direct acting anticoagulant (product)
stroke
renal insufficiency, chronic
atrial fibrillation
warfarin
embolism and thrombosis
Evidence-Based medicine
hemorrhage
warfarin
antithrombins
treatment outcome
Direct factor Xa inhibitors
direct thrombin inhibitors
---
https://dumas.ccsd.cnrs.fr/dumas-01238406
2015
false
false
false
France
French
dissertations, academic
embolism and thrombosis
atrial fibrillation
anticoagulants
vitamin K
antivitamins K
---
https://www.revmed.ch/RMS/2014/RMS-N-412-413/Cardiologie-Tests-de-reactivite-plaquettaire-mise-a-jour-pour-le-praticien
2014
false
false
false
Switzerland
French
journal article
platelet activation
platelet activation
embolism and thrombosis
ticlopidine
ticlopidine
Clopidogrel
---
http://www.cochrane.org/fr/CD007921
2013
false
true
false
United Kingdom
France
embolism and thrombosis
treatment outcome
lower extremity
Axillofemoral Bypass Grafting
review of literature
french abstract
---
https://smf.swisshealthweb.ch/fr/article/doi/fms.2013.01629/
2013
Switzerland
French
anticoagulotherapy
pregnancy complications, cardiovascular
embolism and thrombosis
practice guideline
journal article
pregnancy
postpartum period
postnatal care
chemoprevention
fibrinolytic agents
anticoagulants
---
http://www.john-libbey-eurotext.fr/fr/revues/medecine/stv/e-docs/00/04/06/67/resume.md?type=text.html
http://www.john-libbey-eurotext.fr/fr/revues/medecine/stv/e-docs/00/04/06/67/telecharger.md?code_langue=fr&format=application/pdf&titre=Version
PDF
http://www.john-libbey-eurotext.fr/fr/revues/medecine/stv/e-docs/00/04/06/67/article.md?type=text.html
2004
France
French
journal article
practice guideline
antivitamins K
anticoagulotherapy
anticoagulants
aged
aspirin
risk factors
vitamin K
heparin, low-molecular-weight
anticoagulants
hemorrhage
international normalized ratio
continuity of patient care
age factors
anticoagulants
platelet aggregation inhibitors
platelet aggregation inhibitors
Contraindications, Procedure
Contraindications, Drug
anticoagulants
anticoagulants
heparin, low-molecular-weight
patient education as topic
embolism and thrombosis
embolism and thrombosis
hemorrhage
fibrinolytic agents
fibrinolytic agents
fibrinolytic agents
fibrinolytic agents
fibrinolytic agents
heparin, low-molecular-weight
heparin, low-molecular-weight
heparin, low-molecular-weight
antivitamins K
antivitamins K
indenes
4-hydroxycoumarins
---